Jane Street’s Immunic IMUX Stock Holding History

Jane Street’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	15,300 +2,050	+15%	+$25.3K	﹤0.01%	9739
2026 Q1	$147K	Buy	+13,250	New	+$119K	﹤0.01%	10403

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Jane Street's IMUX Position: Q2 2026 in Review

Jane Street increased its Immunic (IMUX) stake by 36% in Q2 2026, buying an estimated $293K and bringing the position to 89,687 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5860.

Jane Street first reported a position in IMUX in Q2 2014 and has held it in 24 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

Jane Street held 89,687 shares of Immunic worth $1.38M as of Q2 2026.
Jane Street bought 23,772 Immunic shares in Q2 2026, an estimated $293K.
Immunic made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5860 holding.
Jane Street first reported a position in Immunic in Q2 2014 and has held it in 24 quarters since.
55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.